EMA — authorised 29 July 2018
- Marketing authorisation holder: AEGERION PHARMACEUTICALS B.V.
- Status: approved
🇪🇺 Myalept in European Union
EMA authorised Myalept on 29 July 2018
Marketing authorisation
Myalept in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Myalept approved in European Union?
Yes. EMA authorised it on 29 July 2018.
Who is the marketing authorisation holder for Myalept in European Union?
AEGERION PHARMACEUTICALS B.V. holds the EU marketing authorisation.